Immuron IMRN
NASDAQ IMRN
$1.77 -0.07 (-3.80%)
As of: Sep 9, 2026 · 3:59 PM EDT

Immuron (IMRN) Cost of Revenue (2016 - 2025)

Immuron (IMRN) posted Cost of Revenue of $1.6 million for Q2 2025, up 15377.43% on a QoQ basis from $10435.3 in Q3 2024, and up 56.49% year-over-year from $1.0 million in Q2 2024.

Analysis

Immuron (IMRN) Cost of Revenue (2016 - 2025) Analysis & Trends

Immuron has reported Cost of Revenue for 10 years, with the latest figure at $1.6 million in Q2 2025.

  • On a quarterly basis, Cost of Revenue rose 56.49% year-over-year to $1.6 million in Q2 2025; TTM through Jun 2025 was $3.0 million, a 95.46% increase from a year earlier, with the FY2026 full-year figure at $2.7 million, up 10758.98% from the prior year.
  • Cost of Revenue was $1.6 million for Q2 2025 at Immuron, up from $10435.3 in the prior quarter.
  • The five-year high for Cost of Revenue was $1.6 million in Q2 2025, with the low at $508.16 in Q4 2021.
  • Average Cost of Revenue over 5 years is $398762.4, with a median of $97526.7 recorded in 2021.
  • The sharpest annual moves came in 2021 and 2022: Cost of Revenue sank 91.29% in 2021, then soared 30545.09% in 2022.
  • Over 5 years, Cost of Revenue stood at $508.16 in 2021, then jumped by 30545.09% to $155726.0 in 2022, then jumped by 107.16% to $322603.5 in 2023, then slumped by 96.77% to $10435.3 in 2024, then surged by 15377.43% to $1.6 million in 2025.
  • The last three Cost of Revenue figures came in at $1.6 million (Q2 2025), $10435.3 (Q3 2024), and $1.0 million (Q2 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 2.81 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 1.58 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 489.20 Mn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 360.70 Mn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn 145.00 Mn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn 93.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 298.26 Mn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 776.90 Mn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn 284,000.00
10 Immuron 10.28 Mn 1.26 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 1.62 Mn
Sep 9, 2024 10,435.26
Jun 30, 2024 1.03 Mn
Dec 31, 2023 322,603.54
Jun 30, 2023 14,310.93
Dec 31, 2022 155,726.00
Dec 31, 2021 508.16
Jun 30, 2021 39,327.49
Dec 31, 2020 91.25
Jun 30, 2020 451,477.32
Dec 31, 2019 4,351.98
Dec 31, 2018 231,479.00
Dec 31, 2017 150,236.30
Dec 31, 2016 168,434.17
Jun 30, 2016 225,082.24